EUROFINS SCIENTIFIC (ERF.PA) Fundamental Analysis & Valuation
EPA:ERF • FR0014000MR3
Current stock price
69.36 EUR
-0.18 (-0.26%)
Last:
This ERF.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ERF.PA Profitability Analysis
1.1 Basic Checks
- ERF had positive earnings in the past year.
- ERF had a positive operating cash flow in the past year.
- Each year in the past 5 years ERF has been profitable.
- In the past 5 years ERF always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of ERF (3.73%) is comparable to the rest of the industry.
- ERF's Return On Equity of 9.02% is fine compared to the rest of the industry. ERF outperforms 66.67% of its industry peers.
- ERF has a better Return On Invested Capital (6.74%) than 66.67% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ERF is below the industry average of 9.24%.
- The 3 year average ROIC (6.44%) for ERF is below the current ROIC(6.74%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.73% | ||
| ROE | 9.02% | ||
| ROIC | 6.74% |
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
1.3 Margins
- ERF's Profit Margin of 5.62% is in line compared to the rest of the industry. ERF outperforms 50.00% of its industry peers.
- In the last couple of years the Profit Margin of ERF has declined.
- Looking at the Operating Margin, with a value of 10.87%, ERF is doing worse than 61.11% of the companies in the same industry.
- In the last couple of years the Operating Margin of ERF has declined.
- Looking at the Gross Margin, with a value of 21.39%, ERF is doing worse than 77.78% of the companies in the same industry.
- In the last couple of years the Gross Margin of ERF has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.87% | ||
| PM (TTM) | 5.62% | ||
| GM | 21.4% |
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
2. ERF.PA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ERF is destroying value.
- Compared to 1 year ago, ERF has less shares outstanding
- ERF has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for ERF is higher compared to a year ago.
2.2 Solvency
- ERF has an Altman-Z score of 2.59. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of ERF (2.59) is comparable to the rest of the industry.
- ERF has a debt to FCF ratio of 5.14. This is a neutral value as ERF would need 5.14 years to pay back of all of its debts.
- ERF's Debt to FCF ratio of 5.14 is fine compared to the rest of the industry. ERF outperforms 77.78% of its industry peers.
- ERF has a Debt/Equity ratio of 0.82. This is a neutral value indicating ERF is somewhat dependend on debt financing.
- ERF has a Debt to Equity ratio (0.82) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 5.14 | ||
| Altman-Z | 2.59 |
ROIC/WACC0.81
WACC8.36%
2.3 Liquidity
- A Current Ratio of 1.09 indicates that ERF should not have too much problems paying its short term obligations.
- ERF has a Current ratio (1.09) which is in line with its industry peers.
- A Quick Ratio of 1.03 indicates that ERF should not have too much problems paying its short term obligations.
- ERF has a Quick ratio (1.03) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.03 |
3. ERF.PA Growth Analysis
3.1 Past
- ERF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
- The Earnings Per Share has been decreasing by -3.09% on average over the past years.
- Looking at the last year, ERF shows a small growth in Revenue. The Revenue has grown by 4.96% in the last year.
- The Revenue has been growing slightly by 6.05% on average over the past years.
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
3.2 Future
- ERF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.11% yearly.
- ERF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.47% yearly.
EPS Next Y6.38%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
EPS Next 5Y16.11%
Revenue Next Year4.58%
Revenue Next 2Y5.55%
Revenue Next 3Y6.04%
Revenue Next 5Y7.47%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ERF.PA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 18.65, which indicates a rather expensive current valuation of ERF.
- Based on the Price/Earnings ratio, ERF is valued a bit cheaper than the industry average as 72.22% of the companies are valued more expensively.
- ERF is valuated rather cheaply when we compare the Price/Earnings ratio to 27.95, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 18.10 indicates a rather expensive valuation of ERF.
- ERF's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ERF is cheaper than 72.22% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ERF to the average of the S&P500 Index (38.68), we can say ERF is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.65 | ||
| Fwd PE | 18.1 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ERF is valued cheaper than 83.33% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, ERF is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.16 | ||
| EV/EBITDA | 10.47 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ERF does not grow enough to justify the current Price/Earnings ratio.
- ERF's earnings are expected to grow with 13.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.92
PEG (5Y)N/A
EPS Next 2Y11.18%
EPS Next 3Y13.59%
5. ERF.PA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.04%, ERF has a reasonable but not impressive dividend return.
- ERF's Dividend Yield is rather good when compared to the industry average which is at 0.48. ERF pays more dividend than 83.33% of the companies in the same industry.
- With a Dividend Yield of 1.04, ERF pays less dividend than the S&P500 average, which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
5.2 History
- On average, the dividend of ERF grows each year by 16.09%, which is quite nice.
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- ERF pays out 26.80% of its income as dividend. This is a sustainable payout ratio.
- The dividend of ERF is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
ERF.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:ERF (4/21/2026, 5:36:15 PM)
69.36
-0.18 (-0.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29 2026-01-29/bmo
Earnings (Next)04-22 2026-04-22
Inst Owners35.09%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.21B
Revenue(TTM)7.30B
Net Income(TTM)409.70M
Analysts72
Price Target72.19 (4.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.3%
PT rev (3m)5.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.79%
EPS NY rev (3m)-3.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.65 | ||
| Fwd PE | 18.1 | ||
| P/S | 1.67 | ||
| P/FCF | 14.16 | ||
| P/OCF | 8.73 | ||
| P/B | 2.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.47 |
EPS(TTM)3.72
EY5.36%
EPS(NY)3.83
Fwd EY5.52%
FCF(TTM)4.9
FCFY7.06%
OCF(TTM)7.95
OCFY11.46%
SpS41.46
BVpS25.81
TBVpS-4.57
PEG (NY)2.92
PEG (5Y)N/A
Graham Number46.4828 (-32.98%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.73% | ||
| ROE | 9.02% | ||
| ROCE | 9.27% | ||
| ROIC | 6.74% | ||
| ROICexc | 7.43% | ||
| ROICexgc | 23.86% | ||
| OM | 10.87% | ||
| PM (TTM) | 5.62% | ||
| GM | 21.4% | ||
| FCFM | 11.82% |
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)6.44%
ROIC(5y)8.49%
ROICexc(3y)7.17%
ROICexc(5y)9.25%
ROICexgc(3y)23.01%
ROICexgc(5y)30.49%
ROCE(3y)8.97%
ROCE(5y)11.81%
ROICexgc growth 3Y-10.94%
ROICexgc growth 5Y-13.82%
ROICexc growth 3Y-8.95%
ROICexc growth 5Y-10.36%
OM growth 3Y-11.04%
OM growth 5Y-10.39%
PM growth 3Y-13.43%
PM growth 5Y-9.58%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score7
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | 5.14 | ||
| Debt/EBITDA | 2.44 | ||
| Cap/Depr | 74.23% | ||
| Cap/Sales | 7.35% | ||
| Interest Coverage | 6.87 | ||
| Cash Conversion | 92.26% | ||
| Profit Quality | 210.5% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.59 |
F-Score7
WACC8.36%
ROIC/WACC0.81
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.15%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-8.95%
EPS 5Y-3.09%
EPS Q2Q%6.78%
EPS Next Y6.38%
EPS Next 2Y11.18%
EPS Next 3Y13.59%
EPS Next 5Y16.11%
Revenue 1Y (TTM)4.96%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year4.58%
Revenue Next 2Y5.55%
Revenue Next 3Y6.04%
Revenue Next 5Y7.47%
EBIT growth 1Y-4.65%
EBIT growth 3Y-8.54%
EBIT growth 5Y-4.97%
EBIT Next Year81.58%
EBIT Next 3Y28.7%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%
EUROFINS SCIENTIFIC / ERF.PA Fundamental Analysis FAQ
What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.
What is the valuation status for ERF stock?
ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.
What is the profitability of ERF stock?
EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for ERF stock?
The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ERF.PA) is 18.65 and the Price/Book (PB) ratio is 2.69.
What is the financial health of EUROFINS SCIENTIFIC (ERF.PA) stock?
The financial health rating of EUROFINS SCIENTIFIC (ERF.PA) is 5 / 10.